Canadian investment bank AltaCorp Capital has published a research report explaining options for producing cannabinoids from sources beyond cannabis. Analyst and Managing Director David Kideckel, PhD, explained in “Synthetically-Derived...
This article was published originally at 420 Investor in October A highly disruptive technology that I have discussed over the past few years appears to be gaining traction. Biosynthesis,...
Teewinot Life Sciences Corporation, a Global Leader in Pharmaceutical Cannabinoid Production, Secures $12.3 Million Series B Round Furthers Mission to Address Unmet Medical Needs Across the Globe NEW YORK...
Teewinot Life Sciences Corporation’s Subsidiary, Full Spectrum Laboratories, Ltd., Announced Today: Grant of an Important U.S. Patent with Broad Claims to Biosynthetic Production of Cannabinoids Furthers Mission to Address...
In September, the New York Times reported that THC can be produced from yeast. It turns out that not only THC but many of the cannabinoids as well as terpenes...
CBC Biotechnologies, Inc., a Florida-based biopharmaceutical company focused on the use of synthetic biology to produce cannabinoids, has raised $7mm from investors that include NYC-based Tuatara Capital, which is focused...
